. 2020 Oct 5;34(6):2384–2397. doi: 10.1111/jvim.15922

TABLE 2.

Summary of serial evaluations of key clinical variables

	T0	T1	T24
Temperature (°F)	102 (100.9‐102.8)^a	101.6 (100.9‐102.7)	101.4 (100.6‐102.1)	101.3 (100.4‐101.9)	100.9 (100.2‐101.4)^a	101.1 (100.4‐101.7)
Heart rate (bpm)	130 (107‐140)	120 (108‐140)^a,b	120 (91‐131)	112 (100‐120)^a	110 (100‐130)	108 (92‐128)^b
Respiratory rate (rpm)	32 (28‐40)	36 (29–48)	32 (29‐41)	32 (28‐40)	32 (27‐40)	30 (28‐36)
DOGiBAT score (AU)	6 (4‐6)^a	5 (3‐7)	5 (4‐6)	5 (4‐7)^b	4.5 (3.25‐6)^a	5 (3‐6)^b
Hematocrit (%)	36.0 ± 10.9^a	36.4 ± 10.7^b,c	33.5 ± 10.9^a	29.7 ± 9.7^b	30.1 ± 9.3^a	30.0 ± 9.6^c
Platelet count (×10³/μL)	6.0 (0.3‐14.5)	8.0 (0.8‐12)	9.0 (0.0‐13.3)	6.0 (0.0‐15.0)	9.0 (2.3‐18.0)	9.0 (1.0‐35.0)

T24

CPP

Temperature

(°F)

102

(100.9‐102.8)^a

101.6

(100.9‐102.7)

101.4

(100.6‐102.1)

101.3

(100.4‐101.9)

100.9

(100.2‐101.4)^a

101.1

(100.4‐101.7)

Heart rate

(bpm)

130

(107‐140)

120

(108‐140)^a,b

120

(91‐131)

112

(100‐120)^a

110

(100‐130)

108

(92‐128)^b

Respiratory rate

(rpm)

(28‐40)

(29–48)

(29‐41)

(28‐40)

(27‐40)

(28‐36)

DOGiBAT score

(AU)

(4‐6)^a

(3‐7)

(4‐6)

(4‐7)^b

4.5

(3.25‐6)^a

(3‐6)^b

Hematocrit

(%)

36.0 ± 10.9^a

36.4 ± 10.7^b,c

33.5 ± 10.9^a

29.7 ± 9.7^b

30.1 ± 9.3^a

30.0 ± 9.6^c

Platelet count

(×10³/μL)

6.0

(0.3‐14.5)

8.0

(0.8‐12)

9.0

(0.0‐13.3)

6.0

(0.0‐15.0)

9.0

(2.3‐18.0)

9.0

(1.0‐35.0)

Note: Data are presented as mean ± SD or median (IQR). Statistically significant serial comparisons within groups are highlighted by superscript letters. Comparisons between LP and CPP groups are not represented in this table. Variables sharing superscript letters were significantly different (P < .05) by repeated measures ANOVA or the Friedman test.

Abbreviations: AU, arbitrary units; CPP, cryopreserved platelets; LP, lyophilized platelets; T0, baseline immediately prior to transfusion; T1, 1‐hour post‐transfusion completion, T24, 24‐hours post‐transfusion completion.